Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|August 11, 2016

World Courier Opens New Depot in Moscow

The new facility replaces the company’s current Moscow depot and increases its size and capabilities--including local sourcing of comparator drugs and secondary packaging and labeling.

World Courier, a global provider of specialty logistics and a part of AmerisourceBergen, will open a new investigational drug depot in Moscow, Russia, in August. The new facility replaces the company’s current Moscow depot and increases its size and capabilities. New services, include local sourcing of comparator drugs and secondary packaging and labeling, which allows for late-stage customization of products.

Moscow remains an area of interest for clinical trials, and of the 123 new drug therapies approved by CDER in 2015, 50 were studied in Russia. Experts say the number of clinical trials in Russia could double by 2020.

 Read the full release.

 

 


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.